SCHEMBL4650845

SCHEMBL4650845

CC(C(=O)O)[PH](=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29096248 0.97
SCHEMBL4022998 0.78 TP53 (0.44)
Methane SCHEMBL28144392 0.75 TP53 (0.30)
Phosphonic Acid SCHEMBL29287705 0.73 TP53 (0.47)
SCHEMBL28997396 0.73
SCHEMBL21879798 0.73
Methane SCHEMBL28143481 0.73
Lactic Acid SCHEMBL2976569 0.71 TP53 (0.73)
SCHEMBL8901134 0.71 TP53 (0.45)
Alanine SCHEMBL9329114 0.69 SLC7A5 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260083865-A1 PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USE THEREOF 3B PHARMACEUTICALS GMBH (DE) 2026-03-26 US disclosed
US-20240166808-A1 Catalyst Composition For A Polyester Manufacturing Process CLARIANT INTERNATIONAL LTD (CH) 2024-05-23 US disclosed
CN-112778511-B Catalyst composition for polyester production process 科莱恩塑料和涂料有限公司 2023-03-28 CN disclosed
WO-2022123462-A1 RADIOLABELLED PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) INHIBITORS AND USE THEREOF 3B PHARMACEUTICALS GMBH (DE) 2022-06-16 WO disclosed
US-20210214491-A1 CATALYST COMPOSITION FOR A POLYESTER MANUFACTURING PROCESS CLARIANT PLASTICS & COATINGS LTD (CH) 2021-07-15 US disclosed
CN-112778511-A Catalyst composition for polyester production process 科莱恩塑料和涂料有限公司 2021-05-11 CN disclosed
US-10982045-B2 Catalyst composition for a polyester manufacturing process CLARIANT PLASTICS & COATINGS LTD (CH) 2021-04-20 US disclosed
CN-107075097-B Catalyst composition for polyester production process 科莱恩塑料和涂料有限公司 2021-02-05 CN disclosed
EP-3000835-B1 CATALYST COMPOSITION FOR A POLYESTER MANUFACTURING PROCESS CLARIANT INT LTD (CH) 2020-11-25 EP disclosed
EP-3197934-B1 CATALYST COMPOSITION FOR A POLYESTER MANUFACTURING PROCESS CLARIANT PLASTICS & COATINGS LTD (CH) 2019-11-06 EP disclosed
US-20170283549-A1 Catalyst Composition For A Polyester Manufacturing Process CLARIANT PLASTICS & COATINGS LTD (CH) 2017-10-05 US disclosed
EP-3197934-A1 CATALYST COMPOSITION FOR A POLYESTER MANUFACTURING PROCESS Clariant Plastics & Coatings Ltd (CH) 2017-08-02 EP disclosed
WO-2016045923-A1 CATALYST COMPOSITION FOR A POLYESTER MANUFACTURING PROCESS CLARIANT INTERNATIONAL LTD (CH) 2016-03-31 WO disclosed
EP-3000835-A1 Catalyst composition for a polyester manufacturing process Clariant International Ltd. (CH) 2016-03-30 EP disclosed
WO-2013060793-A1 BIFUNCTIONAL LIGANDS FOR RADIOMETALS Technische Universität München (DE) 2013-05-02 WO disclosed
WO-2012150302-A1 TETRAAZA-CYCLOALKANES BASED LIGANDS AND THEIR USE IN NUCLEAR MEDICINE AND MOLECULAR IMAGING Technische Universität München (DE) 2012-11-08 WO disclosed
EP-1968989-A1 SALT OF CARBOXYETHYL PHOSPHINATE ESTER AND FLAME RETARDANT THERMOPLASTIC RESIN COMPOSITION CONTAINING THE SAME Cheil Industries Inc. (KR) 2008-09-17 EP disclosed
WO-2007078028-A1 SALT OF CARBOXYETHYL PHOSPHINATE ESTER AND FLAME RETARDANT THERMOPLASTIC RESIN COMPOSITION CONTAINING THE SAME CHEIL INDUSTRIES INC. (KR) 2007-07-12 WO disclosed
US-6518260-B1 (α-aminophosphino) peptide derivatives, method for making same and therapeutic applications thereof INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2003-02-11 US disclosed
US-6391866-B1 ANALGESICS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2002-05-21 US disclosed